Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Clinical trial NCT05962398 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05962398
- Sponsor
- CSL Behring
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-30
- Primary completion
- 2035-03-23
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.